Status:
COMPLETED
Preop Conformal Radiotherapy - Prostate
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Princess Margaret Hospital, Canada
Conditions:
Prostatic Neoplasm
Eligibility:
MALE
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Radical prostatectomy and radical radiation therapy remain the standard treatment approaches for patients with clinically localized prostate cancer (T1, T2).Radical prostatectomy is most effective whe...
Eligibility Criteria
Inclusion
- Histologically confirmed carcinoma of the prostate
- High risk localized disease defined as clinical T1 or T2 plus \[ (i) Gleason ¡Ý7, PSA\>10 ng/ml and \<35 ng/ml OR (ii) PSA \>15 ng/ml and less \<35 ng/ml (any Gleason) \]
- No evidence of pelvic lymph node metastases on CT scan within 4 months of surgery
- No evidence of distant metastases on bone scan within 4 months of surgery
- No contraindication to pelvic radiation therapy
Exclusion
Key Trial Info
Start Date :
May 1 2000
Trial Type :
INTERVENTIONAL
End Date :
March 1 2009
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00252447
Start Date
May 1 2000
End Date
March 1 2009
Last Update
August 11 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9